Citigroup
AYTU icon

Citigroup’s AYTU BioPharma AYTU Stock Holding History

Citigroup’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39 Buy
+18
New +$40 ﹤0.01% 5726
2026
Q1 		– Sell
-1
Closed -$3 – 5950
2025
Q4 		$3 Hold
1
– – ﹤0.01% 5897
2025
Q3 		$2 Buy
+1
New +$2 ﹤0.01% 6017
2024
Q1 		– Sell
-1
Closed -$3 – 5634
2023
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 5655
2023
Q1 		– Sell
-2,618
Closed -$9.9K – 5492
2022
Q4 		$9.9K Buy
+2,618
New +$9.9K ﹤0.01% 4843
2022
Q3 		– Hold
0
– – – 5825
2022
Q2 		– Hold
0
– – – 6231
2022
Q1 		– Hold
0
– – – 6300
2021
Q4 		– Hold
0
– – – 5818
2021
Q3 		– Sell
-40
Closed -$3K – 5755
2021
Q2 		$4K Sell
40
-76
-66% -$8.92K ﹤0.01% 5867
2021
Q1 		$18K Buy
116
+93
+404% +$14.8K ﹤0.01% 5300
2020
Q4 		$3K Buy
23
+17
+283% +$3.1K ﹤0.01% 7183
2020
Q3 		$1K Sell
6
-9
-60% -$2.31K ﹤0.01% 7351
2020
Q2 		$4K Buy
+15
New +$4.54K ﹤0.01% 7302
2020
Q1 		– Hold
0
– – – 7589
2018
Q1 		– Hold
0
– – – 7528
2017
Q4 		– Hold
0
– – – 7546

Other funds holding AYTU

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Vision Financial Markets
Vision Financial Markets Stamford, Connecticut $131M AUM 8.71% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's AYTU Position: Q3 2026 in Review

Citigroup opened a new position in AYTU BioPharma (AYTU) in Q3 2026: 18 shares worth $39. The stake represents ﹤0.01% of the portfolio and ranks #5726 among its holdings. This is a return to the name: Citigroup previously reported a position in AYTU as recently as Q4 2025.

Citigroup first reported a position in AYTU in Q2 2020 and has held it in 10 quarters since. The position peaked at $18K in Q1 2021. 7 funds tracked by Wall St. Rank hold AYTU as of Q3 2026.

  • Citigroup held 18 shares of AYTU BioPharma worth $39 as of Q3 2026.
  • AYTU BioPharma was a new Citigroup position in Q3 2026.
  • AYTU BioPharma made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5726 holding.
  • Citigroup first reported a position in AYTU BioPharma in Q2 2020 and has held it in 10 quarters since.
  • Citigroup's AYTU BioPharma position peaked at $18K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.